TO THE ISSUE OF MULTIPLE SCLEROSIS EPIDEMIOLOGY
Abstract
The authors carried out a detailed and critical analysis of domestic and foreign literature on the study of the incidence of multiple sclerosis, the characteristics of the disease course in various ethnic groups. At first the disease was described by Charcot in 1868 after the discovery of contrast agents for microscopy, the study of multiple sclerosis became even more active and productive. However, today the issues of etiology and epidemiology remain relevant. In the course of numerous studies, it was determined that the genetic factor plays an important role in the development of multiple sclerosis. At the same time, different ethnic groups with a disease of multiple sclerosis have a different number of genes that contribute to the process. Currently, there is a tendency to increase the incidence among ethnic groups for which multiple sclerosis was not previously characteristic, which contributed to the intensification of research in several countries.
About the Authors
Z. D. Kulbayeva
NC JSC «Karaganda medical university»
Kazakhstan
Kazakhstan
M. A. Grigolashvili
NC JSC «Karaganda medical university»
Kazakhstan
Kazakhstan
S. S. Kaliyev
NC JSC «Karaganda medical university»
Kazakhstan
Kazakhstan
Zh. V. Myasnikov
NC JSC «Karaganda medical university»
Kazakhstan
Kazakhstan
A. .. Zhasulankyzy
NC JSC «Karaganda medical university»
Kazakhstan
Kazakhstan
References
1. Абдрахманова М. Г. Клиническая и эпидемиологическая характеристика рассеянного склероза в Карагандинском регионе /М. Г. Абдрахманова, Р. А. Беляев, Н. В. Тарасова //Журн. неврологии и психиатрии. - 2015. - №2. - С. 5-7.
2. Альмаханова К. К. Сравнительная клинико-эпидемиологическая характеристика рассеянного склероза в северном и южном регионах Казахстана: Автореф. дис..PhD. -Астана, 2016. - 28 с.
3. Гусев Е. И. Рассеянный склероз: Клин. рук. /Е. И. Гусев, И. А. Завалишин, А. Н. Бойко. - М., 2011. - 528 с.
4. Игнатова Ю. Н. Клинико-эпидемиологические характеристики и факторы риска рассеянного склероза в популяции Алтайского края: Автореф. дис..канд. мед. наук. - Барнаул, 2011. - 127 с.
5. Иерусалимский А. П. Эпидемиология рассеянного склероза в Сибири и на Дальнем Востоке (болезненность, заболеваемость) /А. П. Иерусалимский, Б. М. Доронин, Н. А. Малкова //Рассеянный склероз (эпидемиология, новые методы диагностики): Матер. науч.-практ. конф. - Новосибирск: НГМИ, 1985. - С. 3-5.
6. Скоромец А. П. Топическая диагностика заболеваний нервной системы /А. П. Скоромец, Т. А. Скоромец. - М., 2007. - 399 с.
7. Шварц Г. Я. Витамин D и D-гормон. -М.: Анахарсис, 2005. - 152 с.
8. Ahlgren С. High risk of MS in Iranian immigrants in Gothenburg, Sweden /С. Ahlgren, J. Lycke, A. Oden, O. Andersen //SAGE Journals. -2010. - V. 29. - P. 1079-1082.
9. Albor C. Ethnicity and prevalence of multiple sclerosis in east London /C. Albor, Timothy du Sautoy, Narmadha Kali Vanan, B. P. Turner //Multiple Sclerosis Journal. - 2017. - V. 23 (1). - P. 36-42.
10. Alroughani R. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis //R. Alroughani, S. F. Ahmed, J. Al-Hashel //Pediatr. Neurol. - 2015. - V. 53 (6). -P. 508-512.
11. Alroughani R. The prevalence of multiple sclerosis continues to increase in Kuwait /R. Alroughani, F. Al-Hamdan, S. Shuaibi, S. F. Ahmed //Mult. Scler. Relat. Disord. - 2019. - V. 2932. - P. 74-76.
12. Ascherio A. Vitamin D and multiple sclerosis /A. Ascherio, K. L. Munger, K. C. Simon //The Lancet Neurology. - 2010. - V. 9 (6). - P. 599-612.
13. Baranzini S. E. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis /S. E. Baranzini, N. W. Galwey, J. Wang //Hum. Mol. Genet. - 2009. - V. 18 (11). - P. 2078-2090.
14. Bohlega S. Multiple sclerosis in the Arabian Gulf countries: a consensus statement / S. Bohlega, J. Inshasi, A. Rahman //Journ. Neurol. - 2013. - V. 260 (12). - P. 2959-2963.
15. Bronnum-Hansen H. Trends in survival and cause of death in Danish patients with multiple sclerosis /H. Bronnum-Hansen, N. Koch-Henriksen, E. Stenager //Brain. - 2004. - V. 127. -P. 844-850.
16. Browne P. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity /P. Browne, D. Chandraratna, C. Angood //Neurology. - 2014. - V. 83 (11). - P. 1022-1024.
17. Carton H. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium /H. Carton, R. Vlietinck, J. Debruyne //Journ. of neurology, neurosurgery and psychiatry. - 1997. - V. 62. - P. 329-333.
18. Compston A. The distribution of multiple sclerosis. In: Compston /A. Compston, C. Confavreux //McAlpine's Multiple Sclerosis. - Philadelphia, PA, 2006. - P. 71-111.
19. Cotsapas C. Genome-wide association studies of multiple sclerosis /C. Cotsapas, M. Mitrovic //Clinical&Translational Immunology. -2018. - P. 7:e1018.doi:10.1002/cti2.1018.
20. Cottrell D. A. The natural history of multiple sclerosis: a geographically based study. The clinical features and natural history of primary progressive multiple sclerosis /D. A. Cottrell, M. Kremenchutzky, G. P. Rice //Brain. - 1999. - V. 122. - P. 625-639.
21. Dean G. A. Motor neuron disease and multiple sclerosis among immigrants to Britain. London British /G. A. Dean, R. Brady, H. Mcloughlin, M. Elian //Journ. of Preventive and Social Medicine. - 1977. - V. 31. - P. 141-147.
22. Dean G. V. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis /G. V. Dean, M. Elian //Journ. of Neurology, Neurosurgery and Psychiatry - 1997. - V. 63. - P. 565-568.
23. Ebers G. C. The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis /G. C. Ebers, W. J. Koopman, W. Hader //Brain. - 2000. - V. 123. -P. 641-649.
24. Guiyou L. Multiple sclerosis risk pathways differ in Caucasian and Chinese populations /L. Guiyou, F, Zhang, Y, Hu //Journ/ of Neuroimmunology. - 2017. - V. 15. - P. 63-68.
25. Gyllensten H. Сравнение затрат на рассеянный склероз в 3 разных годах: популяционное исследование /h. Gyllensten, M. Wiberg, K. Alexsanderson //Multiple Sclerosis. -2019. - V. 34. - P. 62.
26. Hauser S. L. Multiple sclerosis and other demyelinating diseases /S. L. Hauser, D. S. Goodin //Harrison's Principle of Internal Medicine. -NY: McGraw Hill, 2008. - 230 p.
27. Hedstrom A. K. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis /A. K. Hedstrom, M. Baarnhielm, T. Olsson //Multiple Sclerosis. - 2011. - V. 17 (7). - P. 788-793.
28. Henriksson F. Costs, quality of life and disease severity in MS /F. Henriksson, S. Fredrikson, Т. Masterman //Europ. J. Neurol. - 2001. -V. 8, №1. - P. 27-36.
29. Inshasi J. Prevalence of multiple sclerosis in Dubai, United Arab Emirates /J. Inshasi, M. Thakre //Int. J. Neurosci. - 2011. - V. 121 (7). - P. 393-398.
30. Jersild C. Histocompatibility-linked immune-response determinants in multiple sclerosis /C. Jersild, B. Dupont, T. Fog //Transplant Proc. - 1973. - V. 5 (4). - P. 1791-1796.
31. Kabat E. A. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins /D. H. Moore, H. Landow //J. Clin, Invest. - 1942. - V. 21(5). - P. 571-577.
32. Kesselring J. Differential diagnosis // Multiple sclerosis. - Cambridge: Cambridge University Press, 1997. - P. 214 p.
33. Kingwell E. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada /E. Kingwell, M. van der Kop, Y. Zhao //J. Neurol. Neurosurg. Psychiatry. -2012. - V. 83 (1). - P. 61-66.
34. Kurtzke J. F. Epidemiology in multiple sclerosis: a pilgrim's progress //Brain. - 2013. -V. 136. - P. 2904-2917.
35. Lassmann H. The pathology of multiple sclerosis /H. Lassmann, H. Wekerle //Multiple Sclerosis. - Philadelphia: Elsevier, 2006. - P. 557-599.
36. Leray E. Epidemiology of multiple sclerosis /E. Leray, T. Moreau, A. Fromont //Revue neurologique. - 2016. - V. 72 (1). - P. 3-13.
37. Leray E. Long-term survival of patients with multiple sclerosis in West France /E. Leray, S. Morrissey, J. Yaouanq //Mult. Scler. - 2007. -V. 13 (7). - P. 865-874.
38. Moghaddama V. K. Epidemiology of Multiple Sclerosis in Torbate Heydarieh (Northeast of Iran) during 1982-2016 /V. Moghaddama, K. M. Sarmadib, M. Tatarib //Multiple Sclerosis and Related Disorders. - 2018. - V. 24. - P. 184-189.
39. Murray T. J. The history of multiple sclerosis: the changing frame of the disease over the centuries //J. Neurol. Sci. - 2009. - V. 277. -P. 3-8.
40. Naito S. Multiple sclerosis: association with HL-A3 /S. Naito, N. Namerow, M. R. Mickey //Tissue Antigens. - 1972. - V. 2 (1). - P. 1-4.
41. Noonan C. W. Prevalence estimates for MS in the United States and evidence of an increasing trend for women /C. W. Noonan, S. J. Kathman, M. C. White //Neurology. - 2002. - V. 58 (1). - P. 136-138.
42. Phadke J. G. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in northeast Scotland //J. Neurol. Neurosurg Psychiatry. -1987. - V. 50 (5). - P. 523-531.
43. Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis //J. Neurol. - 2009. - V. 256 (9). - P. 1468-1479.
44. Rivers T. M. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys /T. M. Rivers, F. F. Schwentker //J. Exp. Med. - 1935. - V. 61 (5). -P. 689-702.
45. Rogan E. Activities of the European multiple sclerosis platform //Eur. Neurol. - 2014. -V. 72. - P. 43-46.
46. Rosati G. The prevalence of multiple sclerosis in the world: an update //Neurol. Sci. -2001. - №22 (2). - P. 117-139.
47. Runmarker B. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow up /B. Runmarker, O. Andersen //Brain. - 1993. - V. 17. - P. 116-117.
48. Sadovnick A. D. Life expectancy in patients attending multiple sclerosis clinics /A. D. Sadovnick, G. C. Ebers, R. W. Wilson // Neurology. - 1992. - V. 42 (5). - P. 991-994.
49. Simpson S. Jr. The role of epidemiology in MS research: Past successes, current challenges and future potential /S. Jr. Simpson, B. V. Taylor, I. van der Mei //Mult. Scler. - 2015. - V. 21 (8). - P. 969-977.
50. Viswanathana S. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups /S. Viswanathana, N. Roseb, M. Aripc //Multiple Sclerosis and Related Disorders. - 2018. - V. 25. - P. 300-308.
51. Wang H. Novel variants identified in multiple sclerosis patients from southern China / H. Wang, L. A. Pardeshi, X. Rong //Neurology Volume. - 2007. - V. 68. - P. 1495-1500.
Review
For citations:
Kulbayeva Z.D., Grigolashvili M.A., Kaliyev S.S., Myasnikov Zh.V., Zhasulankyzy A... TO THE ISSUE OF MULTIPLE SCLEROSIS EPIDEMIOLOGY. Medicine and ecology. 2019;(4):11-18. (In Russ.)
Views: 140
Email this article 